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Abstract
Purpose: Patients with left-sided breast cancer frequently receive deep inspiration breath-hold (DIBH) radiotherapy
to reduce the risk of cardiac side effects. The aim of the present study was to analyze intra-breath-hold stability and
inter-fraction breath-hold reproducibility in clinical practice.
Material and methods: Overall, we analyzed 103 patients receiving left-sided breast cancer radiotherapy using a
surface-guided DIBH technique. During each treatment session the vertical motion of the patient was continuously
measured by a surface guided radiation therapy (SGRT) system and automated gating control (beam on/off) was
performed using an audio-visual patient feedback system. Dose delivery was automatically triggered when the
tracking point was within a predefined gating window. Intra-breath-hold stability and inter-fraction reproducibility
across all fractions of the entire treatment course were analyzed per patient.
Results: In the present series, 6013 breath-holds during beam-on time were analyzed. The mean amplitude of the
gating window from the baseline breathing curve (maximum expiration during free breathing) was 15.8 mm (95%-
confidence interval: [8.5–30.6] mm) and had a width of 3.5 mm (95%-CI: [2–4.3] mm). As a measure of intra-breath-
hold stability, the median standard deviation of the breath-hold level during DIBH was 0.3 mm (95%-CI: [0.1–0.9]
mm). Similarly, the median absolute intra-breath-hold linear amplitude deviation was 0.4 mm (95%-CI: [0.01–2.1]
mm). Reproducibility testing showed good inter-fractional reliability, as the maximum difference in the breathing
amplitudes in all patients and all fractions were 1.3 mm on average (95%-CI: [0.5–2.6] mm).
Conclusion: The clinical integration of an optical surface scanner enables a stable and reliable DIBH treatment
delivery during SGRT for left-sided breast cancer in clinical routine.
Keywords: Surface guided radiation therapy, Breast cancer, DIBH, Intra-breath-hold, Inter-fraction, Stability,
Reproducibility, Optical surface scanner
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Introduction
Deep Inspiration Breath-hold (DIBH) is a well-established
radiation technique to achieve a significant cardiac dose
reduction during adjuvant radiotherapy (RT) in left-sided
breast cancer [1–4]. Relative dose reductions of the mean
heart dose (MHD) or the left anterior descending (LAD)
artery by more than 50% as compared to free breathing
(FB) have been reported [4–6]. It has also been shown that
even the mean left lung dose is reduced by about 20% on
average [7]. As a result, heart-sparing techniques provide
a significant risk reduction of major coronary events [8],
as the risk increases linearly with the mean heart dose, by
about 7.4% per Gy [9]. To date, several different breath-
hold techniques are available and used in routine clinical
practice. These techniques differ significantly in terms of
the utilized devices, intrafraction monitoring and patient
feedback systems. In general, a distinction is made be-
tween voluntary or computer-controlled DIBH tech-
niques, such as surface-guided or spirometry-based
systems, respectively [10–13].
The purpose of the present study was to assess intra-
breath-hold stability and breath-hold reproducibility
using an automated surface-based technique. In general,
intrafraction patient movements during breast cancer
radiotherapy could have an impact on adequate dose de-
livery [14–17]. This fact is even more important during
DIBH irradiation, because the target could significantly
move out of the radiation fields if the breath-hold is not
kept at a stable level. Surface guided radiation therapy
(SGRT) offers the possibility to monitor patient move-
ments in real-time using a non-invasive approach, with-
out any additional radiation exposure. SGRT has also
proven to be a reliable tool for patient positioning by
complementing in-room laser-assisted positioning, as
well as for intrafraction monitoring during breast radio-
therapy [18–21]. Moreover, SGRT may even reduce the
frequency of conventional imaging during breast DIBH
RT [22].
The aim of the present study was to analyze intra-
breath-hold stability and inter-fraction reproducibility
during surface-guided breast radiotherapy in a large
study cohort treated with the optical surface imaging
system Catalyst™ (C-Rad, Uppsala, Sweden).
Material and methods
Between February 2017 and October 2018, patients with
left-sided breast cancer treated by surface-guided DIBH
RT at the Department of Radiation Oncology, University
Hospital, LMU Munich were recruited for the present
prospective study. RT related information and patient
characteristics were retrieved from medical records. Pa-
tients were treated either with a conventional fraction-
ated (2Gy in 25 fractions) or a hypofractionated RT
scheme (2.67Gy in 15 fractions). If indicated, a
sequential boost to the tumour bed was applied with a
dose of 5x 2Gy or 8x 2Gy. All treatment plans consisted
of 3D conformal RT (3DCRT) plans using two opposing
tangential beams for the breast/chest wall, with the
addition of 1 to 4 subfields to increase dose homogen-
eity, as well as anterior/posterior fields for regional nodal
irradiation (RNI). The study was approved by the local
ethics committee of the University Hospital, LMU Mun-
ich (No. 352–16 ex 09/2016) and registered at German
Clinical Trials Register (DRKS-ID: DRKS00011407).
Written informed consent was obtained from all
participants.
Optical surface scanning system
The Catalyst™ optical surface scanner uses visible light
to scan the body surface using three charged-coupled
device (CCD) cameras placed in 120-degree angles. Mea-
surements are based on optical triangulation and a
three-dimensional surface image of the scanned area is
calculated [23]. The system allows monitoring the pa-
tient surface by comparing the real-time image with an
initially acquired reference image and calculating abso-
lute position deviations from the surface-projected iso-
center, using a registration algorithm. The system has a
motion detection accuracy of < 0.5 mm for a rigid body.
This was verified by physicists of our institution using
phantom measurements prior to clinical implementation
of the method. A more detailed description of the clin-
ical setting of the present study was reported earlier [4].
Clinical workflow
Prior to CT acquisition, the individual breathing baseline
(the maximum expiration during FB) of each patient was
assessed using the laser-based surface scanner Sentinel™
(C-Rad, Uppsala, Sweden) (see Fig. 1). The gating point
was placed on the patient’s xiphoid process. Patients
were then asked to perform a comfortable DIBH, with-
out any visual feedback. After a few training repetitions,
the gating window was set individually with a maximum
height of 4 mm around the patient-specific vertical dis-
placement measured with the Sentinel™, which was de-
fined by the average displacement from all training
cycles. The gating window is defined as the area of the
respiratory amplitude, where the automated respiratory
gating is performed during treatment delivery (beam on,
see Fig. 2). The width of the gating window was initially
set to 2mm below and above the breath-hold level and
was adjusted individually for each patient. Thereafter,
the procedure was repeated using full audio-visual feed-
back (video goggles) and the simulation CT was per-
formed using a Toshiba Aquillion LB CT Scanner
(Toshiba Medical Systems Corporation, Japan) in DIBH.
In general, the gating window was determined during
the initial simulation CT and was not changed during
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the course of the treatment. At the linac, patient set-up
and DIBH gating was performed using the optical sur-
face scanner Catalyst™. Due to inter-fractional setup vari-
ations, a new baseline was always established at the
beginning of each treatment fraction and the gating win-
dow was automatically set at a relative vertical distance
from this baseline by the Catalyst™ software. Several
breath-holds were required during DIBH treatment: one
breath-hold during each image-guided patient set-up
procedure (e.g. portal imaging) and multiple breath-
holds for dose delivery.
Data processing
Surface-based data including real-time measurements of
the amplitudes along the vertical direction, the breathing
baseline, the width of the gating window and the beam
on/off status were retrieved from the Catalyst™ software
(Fig. 1). All data were extracted from the Catalyst™ soft-
ware and analyzed using MATLAB Release 2018b (The
MathWorks, Inc., Natick, Massachusetts, United States).
DIBH stability and reproducibility
DIBH stability was defined as the amplitude deviation
between baseline and the patien-specific gating window
(during each breath-hold). Therefore, two parameters
were calculated as a measure of stability. The first evalu-
ated parameter was the standard deviation (SD) of the
breath-hold level inside the gating window. The second
parameter was the linear amplitude deviation during a
DIBH maneuver. In this setting, the gradient of a
straight line from a linear regression model is multiplied
with the DIBH-time interval and results in an amplitude
deviation during the DIBH maneuver, as described by
Cervino et al. [24]. An example is given in Fig. 3. Since
the gradient of the linear amplitude deviation can be ei-
ther positive or negative, we also used an absolute linear
deviation parameter especially for correlation analysis.
Moreover, we analyzed the patient-specific inter-
fraction DIBH reproducibility during the entire treat-
ment period (comparing all breath-holds of all treatment
fractions). In this context, reproducibility between
breath-holds was defined as the consistency between the
breathing amplitudes. For this purpose the breathing
Fig. 1 Graphical demonstration of the c4D-Tool; the red point on the patients surface is the reference point for tracking the vertical amplitude
during breath-hold; the lower part of the screenshot shows an amplitude over time-plot
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Fig. 2 Time plot showing the vertical breathing curve amplitude over time; dashed red lines are showing the lower and upper limit of the
gating window
Fig. 3 One deep inspiration breath-hold cycle plot showing the vertical deviation in millimeters over time (blue); the green line is a linear fit plot of the blue
signal (example of the linear function by linear fit: y = 0.0165•time+ 17.69); dashed red lines are showing the lower and upper limit of the gating window
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amplitudes of all breath-holds of a patient were calcu-
lated and the difference between the minimum and the
maximum value was calculated and used as a measure of
reproducibility.
Statistical analysis
Correlation analysis between different parameters was
performed using Spearman’s rank correlation coefficient.
Friedman’s test for coupled samples and a Nemenyi-post-
hoc-analysis was applied for inter-fraction analysis of
DIBH reproducibility. The patient-specific mean DIBH
amplitude of all breath-holds during the entire treatment
course was analyzed. Since there is no normal distribution
for the measured parameters, additional information in-
cluding median values and 95%-confidence intervals were
provided to reliably describe the data distributions. For all
statistical analyses a significance level of α = 0.05 was de-
fined. MATLAB was utilized for data extraction, as well as
data processing and R 3.3.2 with libraries (R.matlab,
ggplot2, plot3D) for statistical analyses.
Results
Patient and tumour characteristics
The present study cohort included 103 patients. Most pa-
tients had early stage breast cancer, classified pT1 (61/103,
59.2%) or pT2 (25/103, 24.3%) with mainly negative nodal
status pN0 (75/103, 72.8%). Overall, 42 patients (40.8%)
received a conventional fractionated RT regimen (2Gy in
25 fractions) to the breast or chest wall, 14% received an
additional irradiation of the regional lymph nodes and
35% received a sequential boost to the tumour bed (2Gy
in 5 or 8 fractions). Table 1 gives an overview including
absolute and relative incidences for different clinicopatho-
logical and radiotherapy parameters.
Descriptive analysis
In summary we analyzed 1944 treatment fractions and
6013 breath-holds during beam-on-time, which corre-
sponds to an average of 3.1 breath-holds during a single
treatment fraction. Breath-holds during image guidance
(portal imaging, CBCT) were excluded from this ana-
lysis. Figure 2 shows a plot of a typical treatment session
showing the baseline, the gating window and multiple
breath-holds over the duration of a treatment fraction.
An overview of the breathing amplitude, defined as the
vertical deviation between breathing baseline and mean
breath-hold level of one deep inspiration breath-hold
within the gating window, is given in Fig. 4a as box plots
for all patients (n = 103) and all breath-holds (n = 6013),
sorted in descending order of the patients’ median
breathing amplitude. Figure 4b represents the frequency
of the breathing amplitudes in a histogram. The breath-
ing amplitude of all patients was 15.8 mm with a SD of
±5.4 mm (95%-CI: [8.5–30.6] mm), the median was 14.7
mm. The mean width of the gating window was 3.5 mm
(95%-CI: [2–4.3] mm). In the present cohort, the mini-
mum width was 2 mm, only two patients had a gating
window of 5 or 6 mm, as it was more difficult for them
to keep a stable DIBH. The mean beam on time during
a single breath-hold was 18.4 s (SD 10.1 s; 95%-CI: [6.6–
34.4] seconds).
Breath-hold stability analysis
The SD of the breath-hold level during the DIBH
showed a value of < 2 mm during all evaluated breath-
holds and the median SD of the breath-hold level was
0.3 mm (95%-CI: [0.1–0.9] mm). Most patients had a SD
of the breath-hold level of < 1 mm during all of their
breath-holds. 95% of all data samples were inside the
interval [− 2; + 2] mm around the mean value. Figure 5a
shows the SD of the breath-hold level inside the gating
window as box plots for each patient and all breath-
holds, the frequency of the SD is indicated in a histo-
gram in Fig. 5b. Furthermore, the breath-hold stability
Table 1 Descriptive patient characteristics and radiotherapy
parameters of the study cohort (n = 103)
No. (%)
Age at diagnosis (yrs.)
mean ± SD 57.7 ± 11 years
median 58.0 years
range 32–80 years
Tumour stage
pTis 11 (10.7%)
pT1 61 (59.2%)
pT2 25 (24.3%)
pT3 4 (3.9%)
pT4 2 (1.9%)
Nodal status
pN0 75 (72.8%)
pN1 15 (14.6%)
pN2 1 (1%)
pN3 1 (1%)
pNx 11 (10.7%)
Fractionation
Normo-fractionated (2/50 Gy) 42 (40.8%)
Hypo-fractionated (2.67/40 Gy) 61 (59.3%)
Boost
no 67 (65%)
yes 36 (35%)
Radiotherapy
Whole-Breast 98 (95.1%)
Chest-wall 5 (4.9%)
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was evaluated using linear deviation analysis (Fig. 5c),
the frequency of the linear deviation is shown in a histo-
gram in Fig. 5d. The median absolute linear deviation
was 0.4 mm (95%-CI: [0.01–2.1] mm), and the mean
value was 0mm (95%-CI: [− 1.6–1.7] mm), indicating
that the drift over time inside the gating window was
limited.
In order to investigate whether there is a correlation
between the median deep inspiration amplitude (gating
window) and the median SD of the breath-hold level, we
applied Spearman’s rank correlation coefficient between
them. The analysis was not statistically significant (rS =
0.1; p = 0.4), meaning that the deep inspiration ampli-
tude (gating window) had no effect on the DIBH stability
during gating. Furthermore, we compared the SD of the
breath-hold level to the linear deviation based on the lin-
ear fit model (compare Fig. 5a, c) and observed a statis-
tical significance (rS = 0.6; p < 0.001).
DIBH reproducibility
The difference between the maximum and minimum
breathing amplitude across all DIBHs of a patient was
calculated, the results were averaged over all patients
and showed a mean value of 1.3 mm (95%-CI: [0.5–2.6]
mm), the SD was 0.6 mm and the median 1.2 mm. Fried-
man’s test for coupled samples of the breathing ampli-
tudes of all breath-holds of a patient during the entire
treatment course was significant (p < 0.001), which
means that the breathing amplitudes between individual
DIBH maneuvers of a patient during the treatment
course were significantly different. In Nemenyi-post-
hoc-analyses there were also significant differences be-
tween the breathing amplitudes of various DIBH cycles
of a patient during all treatment sessions (p < 0.001).
Nevertheless, the maximum differences of the patient-
related breathing amplitudes of all breath-holds during
the whole treatment session and averaged over all pa-
tients were quite small (mean 1.3 mm). Spearman’s rank
correlation was applied between the median deep inspir-
ation amplitude and the maximum difference in the
breathing amplitude across all DIBHs of a patient ana-
lyzed over all patients (rS = 0.2; p = 0.03), additionally we
analyzed the correlation between the SD of the breath-
hold level and the maximum difference in the breathing
amplitude across all DIBHs of a patient over all patients
(rS = 0.4; p < 0.001).
Fig. 4 a Box plots of breathing amplitudes during breath-hold for every patient including all breath-holds sorted by the median value, b
histogram of the breathing amplitudes (n = 103 patients, 6013 breath-holds)
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Discussion
The present study addresses the topic of DIBH stability
and reproducibility during surface-guided left-sided breast
radiotherapy. We report on intra-breath-hold stability and
inter-fraction reproducibility during DIBH radiotherapy in
a large breast cancer patient study population (103 pa-
tients and 6013 breath-holds) treated with an automated
gating technique using an optical surface scanner. It is
known from previous studies, that the Catalyst™ system of-
fers a high level of stability and accuracy in monitoring
breast cancer patients during DIBH compared to other
tracking and guidance systems [25].
In the present series, the breathing amplitude was
15.8 mm. Regarding DIBH stability, the median SD of
the breath-hold level over the entire treatment course
was 0.3 mm (95%-CI: [0.1–0.9] mm), highlighting a high
degree of stability. This could also be verified by a sec-
ond stability parameter based on the linear fit model
(mean value 0 mm (95%-CI: [− 1.6–1.7] mm)). The SD
of the breath-hold level and the stability parameter from
the linear fit model showed a significant correlation and
can therefore be seen as comparable parameters for the
degree of stability (rS = 0.6; p < 0.001). There was no cor-
relation between the median deep inspiration amplitude
(gating window) and the median SD of the breath-hold
level during breath-hold (rS = 0.1; p = 0.4), indicating
that the DIBH amplitude had no effect on the stability
within the gating window. The breathing amplitude be-
tween baseline and gating window has limited impact on
the analyses of the DIBH reproducibility, as the gating
window was individually selected according to the pa-
tient’s ability to maintain a stable breath-hold level.
Since the beam is only triggered inside the gating win-
dow, the breath-hold level inside this window was the
main focus of this study.
For inter-fraction reproducibility, the breathing ampli-
tudes between different DIBH-maneuvers of a patient
during all treatment fractions were compared and
showed significant differences (p < 0.001). The absolute
differences were quite small (mean 1.3 mm). Our results
have shown a significant moderately correlation between
the stability parameter SD and the maximum difference
in the breathing amplitude across all DIBHs of a patient
analyzed over all patients (rS = 0.4; p < 0.001), which
Fig. 5 a Box plots of standard deviation of the breath-hold levels for every patient. b histogram of the standard deviations. c Box plots of the
linear fit amplitude in millimeters inside the gating window during breath-hold for every patient based on linear fit model. d histogram of the
linear fit amplitudes (n = 103 patients, 6013 breath-holds)
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means that a higher stability leads to a higher reproduci-
bility and vice versa.
Similarly to the present analysis, Xiao et al. analyzed
over 7200 DIBH cycles using the surface imaging system
AlignRT (VisionRT, London, UK). The same authors
found a DIBH-stability of < 0.7 mm and a reproducibility
of < 2.2 mm, which is similar to the present results. They
analyzed the median of the 5th–95th percentile range of
the translational displacement during a single breath-
hold or during all breath-holds throughout a single
treatment session [26]. Unfortunately, only the vertical
amplitude could be evaluated with the Catalyst™ system,
which is a limitation of the present study. In contrast,
Fassi et al. observed three-dimensional deviations and
used spirometry-based monitoring of patients with left-
breast DIBH radiotherapy. They analyzed intra-breath-
hold, intrafraction and inter-fraction motion with an in-
frared optical tracking system to assess the variability of
the external surface position in all three directions.
Taken together, intra- breath-hold stability had a median
value of < 1.9 mm in any direction [27].
Similar to this, Kügele et al. have analyzed the intra-
fraction isocenter reproducibility during DIBH-
radiotherapy resulting in a median value of 1 mm in all
three possible directions, however, also values up to 5
mm were observed. In the present study regarding DIBH
reproducibility, only the difference between the max-
imum and the minimum breathing amplitude of a pa-
tient was calculated, which was around 1.1 mm in
median for all patients over the entire treatment course
and is similar to the median value of Kügele et al. [28]
Cervino et al. have analyzed the reproducibility and
stability of DIBH with and without visual feedback. Re-
producibility was defined as the maximum difference be-
tween the mean values of individual absolute breathing
amplitudes during breath-hold of a patient during one
treatment session. The higher the difference between the
individual DIBH maneuvers, the worse the reproducibil-
ity. The authors concluded that there is a significant dif-
ference between the use and omission of video feedback.
With video feedback (analogous to our setting) the re-
producibility was 0.5 mm and the stability was 0.7 mm
[24]. In the present study, the slope inside the gating
window and subsequently the drift over time was quite
small (median < 0.4 mm), which shows similar results.
Stock et al. have shown that the addition of video feed-
back in DIBH improved the relative reproducibility in
over 524 DIBH maneuvers [29]. Therefore, video feed-
back is a standard procedure at our institution during
DIBH radiotherapy.
In a previous published study [19], a large study cohort
of breast cancer patients was observed by intrafraction
surface monitoring during free breathing RT (without
DIBH). All data samples of the vertical amplitude
deviation during beam-on-time were averaged over all
treatment sessions and all patients, the mean and stand-
ard deviation were 0.4 ± 1mm (95%-CI: [− 1.6–2.6] mm).
In the current setting, all patients were treated with
DIBH and the median SD of the breath-hold level was
much smaller: 0.3 mm (95%-CI: [0.1–0.9] mm). There-
fore, the SD of the breath-hold level during DIBH RT is
over half the size smaller than the one in free breathing.
One relevant factor is that patients were performing
breathing maneuvers and were therefore actively paying
attention to their breathing patterns. Another important
aspect is the video feedback for the patient, which gives
the patient an immediate feedback about the breathing
excursions so that the patient can react before a relevant
deviation occurs [19].
A main advantage of the surface scanning system used
in the present study is the automated gating mechanism.
If the breath-hold level falls out of the gating window,
the irradiation is stopped automatically without the need
for any manual intervention. Based on a typical ±2 x
SD-interval ([− 2; + 2] mm) that covers over 95% of all
values around the mean value, a gating window width of
4 mm seems to be an appropriate choice. Nevertheless,
one of the limitations of the present study is that based
on a technical limitations only vertical deviations are
monitored by the Catalyst™ system, as longitudinal, lat-
eral and rotational deviations are not recorded during
gated RT.
Conclusion
The SGRT system enabled a stable and reliable DIBH
treatment delivery in left-sided breast cancer in a large
cohort (103 patients, 1944 treatment fractions, 6013
breath-holds). As a measure of DIBH stability, the me-
dian SD and absolute linear deviation of the breath-hold
level inside the gating window were both < 0.5 mm. Re-
garding reproducibility of DIBHs, the differences of the
breathing amplitudes in all patients and all treatment
fractions were 1.3 mm on average.
Abbreviations
CCD: Charged-coupled device; CI: Confidence interval; DIBH: Deep inspiration
breath-hold; IMRT: Intensity modulated radiation therapy; MRI: Magnetic
resonance imaging; RT: Radiotherapy; SD: Standard deviation;
VMAT: Volumetric Arc Therapy; FB: Free breathing; CT : Computed
tomography; SGRT: Surface guided radiotherapy; LAD: Left artery descending;
MHD: Mean heart dose; CBCT: Conebeam CT
Acknowledgements
Not applicable.
Authors’ contributions
DR performed data extraction, data processing, the statistical analysis and
drafted the manuscript. PF helped in data extraction & processing. CB, PF,
FW, SS, MP, GL, EB, CM and MN reviewed the manuscript. SC and AF helped
to finalize the manuscript. PF and MR planned and organized the technical
settings. CB and SC designed and supervised the study. All authors read and
approved the final manuscript.
Reitz et al. Radiation Oncology          (2020) 15:121 Page 8 of 9
Funding
Not applicable.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
The study was approved by the local ethics committee of the University
Hospital, LMU Munich (No. 352–16 ex 09/2016) and registered at German
Clinical Trials Register (DRKS-ID: DRKS00011407, registered 12 January 2017,
www.drks.de). Written informed consent was obtained for all patients.
Consent for publication
Not applicable.
Competing interests
CB, PF received research grants and MR, SC, PF speaker honoraria from C-
RAD. The other authors declare that they have no competing interests.
Glossary
baseline
maximum vertical expiration level during free breathing within one
fraction
breath-hold level
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